Topic: Eli Lilly and Company
Eli Lily Pays Mississippi $18.5 Million to Settle Zyprexa Claim
consumeraffairs.com
Money arrives at critical time, state saysThe State of Mississippi has recovered some much needed cash, as drug giant Eli Lilly has agreed to an $18.5 million fraud settlement over the drug Zyprexa. The drug was only approved for major psychotic disorders, but the state alleged that the drug ...
Miss. settles Zyprexa suit for more than $18M
AP Features
Mississippi will receive $18.5 million from drug maker Eli Lilly and Co. as part of a settlement over claims the company promoted the anti-psychotic Zyprexa for ailments it was not federally approved to treat, Attorney General Jim Hood said Thursday. The settlement recovers money the state spent through its ...
Drugmakers post higher sales but a mix on profits
AP Features
Fourth-quarter revenues climbed about 10 percent for major drugmakers AstraZeneca PLC, Bristol-Myers Squibb Co. and Eli Lilly & Co., mainly buoyed by sales of drugs for heart disease, depression and other mental illnesses. But one-time charges muddied the profit picture, while two heavily touted new drugs tanked and the companies ...
On the Call: Eli Lilly CEO John Lechleiter
AP News
Lilly CEO discusses new blood thinner Effient and its slow startEli Lilly and Co. reported a profit and better-than-expected revenue for the fourth quarter, but sales of its newest drug, the blood thinner Effient, slid. Lilly launched the drug in August, and it rang up $22.6 million in third-quarter ...
Related Videos by 5min
on OneRiot
Related Photos by Flickr
